[types field=’month’][/types]

[types field=’year’][/types]

Health Canada Approves Otsuka and Lundbeck’s REXULTI® (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder

[types field=’location’][/types]
[types field=’full-article’][/types]